{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T06:28:03Z","timestamp":1792218483286,"version":"4.4.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T00:00:00Z","timestamp":1545350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T00:00:00Z","timestamp":1545350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Robust surveillance methods are needed for trachoma control and recrudescence monitoring, but existing methods have limitations. Here, we analyse data from nine trachoma-endemic populations and provide operational thresholds for interpretation of serological data in low-transmission and post-elimination settings. Analyses with sero-catalytic and antibody acquisition models provide insights into transmission history within each population. To accurately estimate sero-conversion rates (SCR) for trachoma in populations with high-seroprevalence in adults, the model accounts for secondary exposure to <jats:italic>Chlamydia trachomatis<\/jats:italic> due to urogenital infection. We estimate the population half-life of sero-reversion for anti-Pgp3 antibodies to be 26 (95% credible interval (CrI): 21\u201334) years. We show SCRs below 0.015 (95% confidence interval (CI): 0.0\u20130.049) per year correspond to a prevalence of trachomatous inflammation\u2014follicular below 5%, the current threshold for elimination of active trachoma as a public health problem. As global trachoma prevalence declines, we may need cross-sectional serological survey data to inform programmatic decisions.<\/jats:p>","DOI":"10.1038\/s41467-018-07852-0","type":"journal-article","created":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T16:35:47Z","timestamp":1545064547000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["The utility of serology for elimination surveillance of trachoma"],"prefix":"10.1038","volume":"9","author":[{"given":"Amy","family":"Pinsent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony W.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin L.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhiannon","family":"Bid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anaseini","family":"Cama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brook","family":"Goodhew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Gwyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin R.","family":"Jack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram Prasad","family":"Kandel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Kama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Massae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Macleod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C. W.","family":"Mabey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Migchelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Sandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Sokana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raebwebwe","family":"Taoaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabebe","family":"Tekeraoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana L.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael. T.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,21]]},"reference":[{"key":"7852_CR1","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1128\/mr.58.4.686-699.1994","volume":"58","author":"WL Beatty","year":"1994","unstructured":"Beatty, W. L., Morrison, R. P. & Byrne, G. I. Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol. Rev. 58, 686\u2013699 (1994).","journal-title":"Microbiol. Rev."},{"key":"7852_CR2","unstructured":"WHO Alliance for the Global Elimination of Trachoma by 2020: progress report on elimination of trachoma, 2014\u20132016. Wkly. Epidemiol. Rec. 92, 359\u2013368 (2017)."},{"key":"7852_CR3","doi-asserted-by":"publisher","first-page":"e0005080","DOI":"10.1371\/journal.pntd.0005080","volume":"10","author":"AM Ramadhani","year":"2016","unstructured":"Ramadhani, A. M., Derrick, T., Macleod, D., Holland, M. J. & Burton, M. J. The relationship between active trachoma and ocular chlamydia trachomatis infection before and after mass antibiotic treatment. PLoS Negl. Trop. Dis. 10, e0005080 (2016).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"7852_CR4","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3109\/09286586.2015.1037401","volume":"22","author":"AW Solomon","year":"2015","unstructured":"Solomon, A. W. et al. The global trachoma mapping project: methodology of a 34-country population-based study. Ophthalmic Epidemiol. 22, 214\u2013225 (2015).","journal-title":"Ophthalmic Epidemiol."},{"key":"7852_CR5","doi-asserted-by":"publisher","first-page":"e0005616","DOI":"10.1371\/journal.pntd.0005616","volume":"11","author":"BF Arnold","year":"2017","unstructured":"Arnold, B. F. et al. Measuring changes in transmission of neglected tropical diseases, malaria, and enteric pathogens from quantitative antibody levels. PLoS. Negl. Trop. Dis. 11, e0005616 (2017).","journal-title":"PLoS. Negl. Trop. Dis."},{"key":"7852_CR6","doi-asserted-by":"crossref","unstructured":"Stresman, G., Cameron, A. & Drakeley, C. Freedom from infection: confirming interruption of malaria transmission. Trends Parasitol. 33, 345\u2013352 (2017).","DOI":"10.1016\/j.pt.2016.12.005"},{"key":"7852_CR7","doi-asserted-by":"publisher","first-page":"e1873","DOI":"10.1371\/journal.pntd.0001873","volume":"6","author":"EB Goodhew","year":"2012","unstructured":"Goodhew, E. B. et al. CT694 and pgp3 as serological tools for monitoring trachoma programs. PLoS Negl. Trop. Dis. 6, e1873 (2012).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"7852_CR8","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.pt.2007.08.023","volume":"23","author":"P Corran","year":"2007","unstructured":"Corran, P., Coleman, P., Riley, E. & Drakeley, C. Serology: a robust indicator of malaria transmission intensity? Trends Parasitol. 23, 575\u2013582 (2007).","journal-title":"Trends Parasitol."},{"key":"7852_CR9","doi-asserted-by":"publisher","first-page":"5108","DOI":"10.1073\/pnas.0408725102","volume":"102","author":"CJ Drakeley","year":"2005","unstructured":"Drakeley, C. J. et al. Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc. Natl Acad. Sci. USA 102, 5108\u20135113 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7852_CR10","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1186\/s13071-016-1623-1","volume":"9","author":"A Golden","year":"2016","unstructured":"Golden, A. et al. Analysis of age-dependent trends in Ov16 IgG4 seroprevalence to onchocerciasis. Parasit. Vectors 9, 338 (2016).","journal-title":"Parasit. Vectors"},{"key":"7852_CR11","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.epidem.2017.02.004","volume":"18","author":"SM Bartsch","year":"2017","unstructured":"Bartsch, S. M. et al. Comparison and validation of two computational models of Chagas disease: a thirty year perspective from Venezuela. Epidemics 18, 81\u201391 (2017).","journal-title":"Epidemics"},{"key":"7852_CR12","doi-asserted-by":"publisher","first-page":"769","DOI":"10.4269\/ajtmh.2009.80.769","volume":"80","author":"JM Mladonicky","year":"2009","unstructured":"Mladonicky, J. M. et al. Assessing transmission of lymphatic filariasis using parasitologic, serologic, and entomologic tools after mass drug administration in american samoa. Am. J. Trop. Med. Hyg. 80, 769\u2013773 (2009).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"7852_CR13","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1128\/CVI.00021-09","volume":"16","author":"GS Wills","year":"2009","unstructured":"Wills, G. S. et al. Pgp3 antibody enzyme-linked immunosorbent assay, a sensitive and specific assay for seroepidemiological analysis of Chlamydia trachomatis infection. Clin. Vaccine Immunol. 16, 835\u2013843 (2009).","journal-title":"Clin. Vaccine Immunol."},{"key":"7852_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15056-7","volume":"7","author":"SJ Migchelsen","year":"2017","unstructured":"Migchelsen, S. J. et al. Serology reflects a decline in the prevalence of trachoma in two regions of The Gambia. Sci. Rep. 7, 15040 (2017).","journal-title":"Sci. Rep."},{"key":"7852_CR15","doi-asserted-by":"publisher","first-page":"e0005003","DOI":"10.1371\/journal.pntd.0005003","volume":"10","author":"AI Zambrano","year":"2016","unstructured":"Zambrano, A. I. et al. The World health organization recommendations for trachoma surveillance, experience in nepal and added benefit of testing for antibodies to Chlamydia trachomatis pgp3 Protein: NESTS Study. PLoS Negl. Trop. Dis. 10, e0005003 (2016).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"7852_CR16","doi-asserted-by":"publisher","first-page":"e0003555","DOI":"10.1371\/journal.pntd.0003555","volume":"9","author":"DL Martin","year":"2015","unstructured":"Martin, D. L. et al. Serology for Trachoma surveillance after cessation of mass drug administration. PLoS Negl. Trop. Dis. 9, e0003555 (2015).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"7852_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/srep19472","volume":"6","author":"V Yman","year":"2016","unstructured":"Yman, V. et al. Antibody acquisition models: a new tool for serological surveillance of malaria transmission intensity. Sci. Rep. 6, 19472 (2016).","journal-title":"Sci. Rep."},{"key":"7852_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/srep18532","volume":"5","author":"DL Martin","year":"2015","unstructured":"Martin, D. L. et al. Serological measures of trachoma transmission intensity. Sci. Rep. 5, 18532 (2015).","journal-title":"Sci. Rep."},{"key":"7852_CR19","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1017\/S0950268899003076","volume":"123","author":"R Bailey","year":"1999","unstructured":"Bailey, R., Duong, T., Carpenter, R., Whittle, H. & Mabey, D. The duration of human ocular Chlamydia trachomatis infection is age dependent. Epidemiol. Infect. 123, 479\u2013486 (1999).","journal-title":"Epidemiol. Infect."},{"key":"7852_CR20","doi-asserted-by":"publisher","first-page":"e341","DOI":"10.1371\/journal.pntd.0000341","volume":"2","author":"NC Grassly","year":"2008","unstructured":"Grassly, N. C., Ward, M. E., Ferris, S., Mabey, D. C. & Bailey, R. L. The Natural history of trachoma infection and disease in a gambian cohort with frequent follow-up. PLoS Negl. Trop. Dis. 2, e341 (2008).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"7852_CR21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1600-065X.2010.00912.x","volume":"236","author":"IJ Amanna","year":"2010","unstructured":"Amanna, I. J. & Slifka, M. K. Mechanisms that determine plasma cell lifespan and the duration of humoral immunity. Immunol. Rev. 236, 125\u2013138 (2010).","journal-title":"Immunol. Rev."},{"key":"7852_CR22","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/8451","volume":"5","author":"T Lietman","year":"1999","unstructured":"Lietman, T., Porco, T., Dawson, C. & Blower, S. Global elimination of trachoma: how frequently should we administer mass chemotherapy? Nat. Med. 5, 572\u2013576 (1999).","journal-title":"Nat. Med."},{"key":"7852_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-216","volume":"14","author":"EB Goodhew","year":"2014","unstructured":"Goodhew, E. B. et al. Longitudinal analysis of antibody responses to trachoma antigens before and after mass drug administration. BMC Infect. Dis. 14, 216 (2014).","journal-title":"BMC Infect. Dis."},{"key":"7852_CR24","doi-asserted-by":"publisher","first-page":"e0006023","DOI":"10.1371\/journal.pntd.0006023","volume":"11","author":"G Trotignon","year":"2017","unstructured":"Trotignon, G. et al. The cost of mapping trachoma: data from the Global Trachoma Mapping Project. PLoS Negl. Trop. Dis. 11, e0006023 (2017).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"7852_CR25","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1136\/bjophthalmol-2012-302050","volume":"96","author":"SJ Bhosai","year":"2012","unstructured":"Bhosai, S. J. et al. Application of smartphone cameras for detecting clinically active trachoma. Br. J. Ophthalmol. 96, 1350 (2012).","journal-title":"Br. J. Ophthalmol."},{"key":"7852_CR26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.12688\/wellcomeopenres.13423.2","volume":"3","author":"R Butcher","year":"2018","unstructured":"Butcher, R. et al. Clinical signs of trachoma are prevalent among Solomon Islanders who have no persistent markers of prior infection with Chlamydia trachomatis. Wellcome Open Res. 3, 14 (2018).","journal-title":"Wellcome Open Res."},{"key":"7852_CR27","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1136\/sti.2004.011817","volume":"81","author":"P Christian","year":"2005","unstructured":"Christian, P. et al. Prevalence and risk factors of chlamydia and gonorrhea among rural Nepali women. Sex. Transm. Infect. 81, 254\u2013258 (2005).","journal-title":"Sex. Transm. Infect."},{"key":"7852_CR28","doi-asserted-by":"crossref","unstructured":"Marks, M. et al. Prevalence of sexually transmitted infections in female clinic attendees in Honiara, Solomon Islands. BMJ Open 5, e0072 (2015).","DOI":"10.1136\/bmjopen-2014-007276"},{"key":"7852_CR29","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1093\/trstmh\/trw069","volume":"110","author":"N Cocks","year":"2016","unstructured":"Cocks, N. et al. Community seroprevalence survey for yaws and trachoma in the Western Division of Fiji. Trans. R. Soc. Trop. Med. Hyg. 110, 582\u2013587 (2016).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"7852_CR30","volume-title":"Validation of Elimination Of Trachoma As A Public Health Problem (WHO\/HTM\/NTD\/2016.8)","author":"World Health Organization.","year":"2016","unstructured":"World Health Organization. Validation of Elimination Of Trachoma As A Public Health Problem (WHO\/HTM\/NTD\/2016.8). (World Health Organization, Geneva, 2016)."},{"key":"7852_CR31","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.3201\/eid2407.171928","volume":"24","author":"BF Arnold","year":"2018","unstructured":"Arnold, B. F., Scobie, H. M., Priest, J. W. & Lammie, P. J. Integrated serologic surveillance of population immunity and disease transmission. Emerg. Infect. Dis. 24, 1188\u20131194 (2018).","journal-title":"Emerg. Infect. Dis."},{"key":"7852_CR32","doi-asserted-by":"publisher","first-page":"e1746","DOI":"10.1371\/journal.pntd.0001746","volume":"6","author":"AW Solomon","year":"2012","unstructured":"Solomon, A. W. et al. A diagnostics platform for the integrated mapping, monitoring, and surveillance of neglected tropical diseases: rationale and target product profiles. PLoS Negl. Trop. Dis. 6, e1746 (2012).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"7852_CR33","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3389\/fmed.2017.00251","volume":"4","author":"RMR Butcher","year":"2017","unstructured":"Butcher, R. M. R. et al. Active trachoma cases in the solomon islands have varied polymicrobial community structures but do not associate with individual non-chlamydial pathogens of the eye. Front. Med. 4, 251 (2017).","journal-title":"Front. Med."},{"key":"7852_CR34","doi-asserted-by":"publisher","first-page":"216","DOI":"10.4269\/ajtmh.17-0102","volume":"98","author":"SE Gwyn","year":"2018","unstructured":"Gwyn, S. E. et al. Prevalence of Chlamydia trachomatis-specific antibodies before and after mass drug administration for Trachoma in community-wide surveys of four communities in Nepal. Am. J. Trop. Med. Hyg. 98, 216\u2013220 (2018).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"7852_CR35","doi-asserted-by":"publisher","first-page":"e0005863","DOI":"10.1371\/journal.pntd.0005863","volume":"11","author":"A Cama","year":"2017","unstructured":"Cama, A. et al. Prevalence of signs of trachoma, ocular Chlamydia trachomatis infection and antibodies to Pgp3 in residents of Kiritimati Island, Kiribati. PLoS Negl. Trop. Dis. 11, e0005863 (2017).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"7852_CR36","doi-asserted-by":"publisher","first-page":"738030","DOI":"10.1155\/2015\/738030","volume":"2015","author":"N Sepulveda","year":"2015","unstructured":"Sepulveda, N., Stresman, G., White, M. T. & Drakeley, C. J. Current mathematical models for analyzing anti-malarial antibody data with an eye to malaria elimination and eradication. J. Immunol. Res. 2015, 738030 (2015).","journal-title":"J. Immunol. Res."},{"key":"7852_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-015-0661-z","volume":"14","author":"N Sep\u00falveda","year":"2015","unstructured":"Sep\u00falveda, N. & Drakeley, C. Sample size determination for estimating antibody seroconversion rate under stable malaria transmission intensity. Malar. J. 14, 141 (2015).","journal-title":"Malar. J."},{"key":"7852_CR38","doi-asserted-by":"crossref","unstructured":"Gelman, A. & Rubin, D. B. Inference from iterative simulation using multiple sequences. Stat. Sci, 7, 457\u2013472 (1992).","DOI":"10.1214\/ss\/1177011136"},{"key":"7852_CR39","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/1467-9868.00353","volume":"64","author":"DJ Spiegelhalter","year":"2002","unstructured":"Spiegelhalter, D. J., Best, N. G., Carlin, B. P. & Van Der Linde, A. Bayesian measures of model complexity and fit. J. R. Stat. Soc. B 64, 583\u2013639 (2002).","journal-title":"J. R. Stat. Soc. B"},{"key":"7852_CR40","unstructured":"R: A language and environment for statistical computing (R Foundation for statistical computing, Vienna, Austria)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-07852-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-07852-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-07852-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T21:43:56Z","timestamp":1671572636000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-07852-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,21]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["7852"],"URL":"https:\/\/doi.org\/10.1038\/s41467-018-07852-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,21]]},"assertion":[{"value":"25 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5444"}}